Related references
Note: Only part of the references are listed.State-of-the-art in the management of locally advanced and metastatic gallbladder cancer
Mairead G. McNamara et al.
CURRENT OPINION IN ONCOLOGY (2013)
Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro
Dehao Fu et al.
BMC MUSCULOSKELETAL DISORDERS (2011)
Inhibition of tumor growth and vasculogenic mimicry by cucumin through downregulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model
Lu-Xia Chen et al.
CANCER BIOLOGY & THERAPY (2011)
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro
Wei Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma
Man Li et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy
Yue-Zu Fan et al.
WORLD JOURNAL OF GASTROINTESTINAL SURGERY (2010)
Gallbladder Cancer: We Need to Do Better!
Parul J. Shukla et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades A Single-Institution Experience
Ioannis T. Konstantinidis et al.
ARCHIVES OF SURGERY (2009)
Factors Influencing Long-Term Survival in Patients with T3 Gallbladder Adenocarcinoma
K. Dilip Chakravarty et al.
DIGESTION (2009)
Prognostic Role of Vasculogenic Mimicry in Colorectal Cancer
Coen I. M. Baeten et al.
DISEASES OF THE COLON & RECTUM (2009)
Bevacizumab: current indications and future development for management of solid tumors
Jenia Jenab-Wolcott et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Biological mechanisms of bevacizumab-associated adverse events
Gerald M. Higa et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2009)
Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells
Rihong Cong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Adverse effects of anticancer agents that target the VEGF pathway
Helen X. Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules
Axel Grothey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Surgical Management of Gallbladder Cancer
Srinevas K. Reddy et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
Angiopoietin-2: Development of Inhibitors for Cancer Therapy
Bo Hu et al.
CURRENT ONCOLOGY REPORTS (2009)
A new era for Journal of Experimental & Clinical Cancer Research
Mauro Castelli
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease
Pablo Mojica et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Antiangiogenesis in cancer therapy - endostatin and its mechanisms of action
J Folkman
EXPERIMENTAL CELL RESEARCH (2006)
Antiangiogenic cancer therapies get their act together: current developments and future prospects of growth factor- and growth factor receptor-targeted approaches
J Gille
EXPERIMENTAL DERMATOLOGY (2006)
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo
F Tian et al.
CANCER BIOLOGY & THERAPY (2005)
Membrane localization of all class IPI 3-kinase isoforms suppresses c-Myc-induced apoptosis in Rat1 fibroblasts via Akt
W Link et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Functional role of matrix metalloproteinases in ovarian tumor cell plasticity
AK Sood et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways
W An et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells
DWJ van der Schaft et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Chemotherapy in the treatment of advanced gallbladder cancer
H Ishii et al.
ONCOLOGY (2004)
Vasculogenic mimicry and pseudo-comedo formation in breast cancer
K Shirakawa et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
J Lawler
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Epidemiology and molecular pathology of gallbladder cancer
EC Lazcano-Ponce et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2001)
Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety
YP Ho et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Matrix metalloproteinases: multifunctional contributors to tumor progression
LJ McCawley et al.
MOLECULAR MEDICINE TODAY (2000)
Share Paper
